Lilly Announces Significant Global Insulin Manufacturing Capacity Investments
Thursday, November 14th is World Diabetes Day---and Eli Lilly has announced a major investment in its ongoing battle against the global epidemic.
The Indianapolis-based company plans to invest more than 700 million dollars to enhance insulin production operations in Indianapolis, Puerto Rico, France and China.
"Insulin is a cornerstone of diabetes treatment and its use will only continue to increase given the rising number of people with diabetes around the world," said Enrique Conterno, senior vice president and president, Lilly Diabetes. "Since introducing the first commercially available insulin 90 years ago, Lilly has helped address the global diabetes burden, and today's announcement further underscores our deep commitment to diabetes care."
Lilly has been manufacturing insulin since it introduced the first commercially available insulin product in 1923. New figures released from the International Diabetes Federation show 382 million adults around the world have diabetes, and that number is projected to rise to 592 million over the next 25 years.